Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma 19Lymphoma, Large B-Cell, Diffuse 17Hodgkin Disease 8Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 5Leukemia 5Hemangioma 5Lymphoma, Large-Cell, Anaplastic 4Prostatic Neoplasms 3Neoplasms 3Lymphoma, B-Cell 3Immunoblastic Lymphadenopathy 3Neurotoxicity Syndromes 2Neoplasm, Residual 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Esophageal Stenosis 2Enteropathy-Associated T-Cell Lymphoma 2Vomiting 1Thymoma 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Polycystic Ovary Syndrome 1Philadelphia Chromosome 1Neoplasm Metastasis 1Neoadjuvant Therapy 1Nausea 1

Interventions

Cyclophosphamide 64fludarabine phosphate 37Peripheral Blood Stem Cell Transplantation 30Cyclosporine 30Radiotherapy 28Mycophenolic Acid 28Filgrastim 28Busulfan 28Whole-Body Irradiation 26Antilymphocyte Serum 24Melphalan 19Etoposide 19Tacrolimus 16Methotrexate 16Cord Blood Stem Cell Transplantation 16Methylprednisolone 15Rituximab 14Thiotepa 10Cytarabine 10Vincristine 8Prednisone 8Doxorubicin 8Carboplatin 7fludarabine 5Sirolimus 5sargramostim 4glofitamab 4aldesleukin 4Therapeutics 4Leucovorin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Dendritic Cell Sarcoma, Interdigitating × Prednisolone × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡